1. Home
  2. AUPH vs BLMN Comparison

AUPH vs BLMN Comparison

Compare AUPH & BLMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Aurinia Pharmaceuticals Inc

AUPH

Aurinia Pharmaceuticals Inc

HOLD

Current Price

$15.88

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

BLMN

Bloomin' Brands Inc.

HOLD

Current Price

$6.32

Market Cap

557.3M

ML Signal

HOLD

Company Overview

Basic Information
Metric
AUPH
BLMN
Founded
1993
1988
Country
Canada
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Restaurants
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
557.3M
IPO Year
1999
2012

Fundamental Metrics

Financial Performance
Metric
AUPH
BLMN
Price
$15.88
$6.32
Analyst Decision
Buy
Hold
Analyst Count
4
8
Target Price
$17.25
$8.50
AVG Volume (30 Days)
1.2M
1.9M
Earning Date
11-04-2025
11-06-2025
Dividend Yield
N/A
6.63%
EPS Growth
N/A
N/A
EPS
0.55
N/A
Revenue
$265,808,000.00
$3,952,793,000.00
Revenue This Year
$21.76
$2.19
Revenue Next Year
$16.45
$0.32
P/E Ratio
$29.54
N/A
Revenue Growth
20.62
7.72
52 Week Low
$6.55
$5.90
52 Week High
$16.54
$12.97

Technical Indicators

Market Signals
Indicator
AUPH
BLMN
Relative Strength Index (RSI) 54.66 40.74
Support Level $16.00 $6.45
Resistance Level $16.54 $6.82
Average True Range (ATR) 0.40 0.29
MACD -0.06 -0.05
Stochastic Oscillator 52.52 0.49

Price Performance

Historical Comparison
AUPH
BLMN

About AUPH Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing AUR200, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.

About BLMN Bloomin' Brands Inc.

Bloomin Brands Inc operates as a casual dining restaurant company. The company's brand includes Outback Steakhouse, Carrabba's Italian Grill, Bonefish Grill, and Fleming's Prime Steakhouse and Wine Bar. The company owns and operates its restaurants, and the remainder is franchised. It derives revenue mainly from the United States, but the company has a presence in Brazil and South Korea with company-owned Outbacks and Carrabbas. In addition, it also has exposure to several countries, predominantly in Asia, principally through franchising. The Company aggregates its operating segments into two reportable segments, U.S. and international. The U.S. segment includes all restaurants operating in the U.S. while restaurants operating outside the U.S. are included in the international segment.

Share on Social Networks: